Sanofi is an R&D-driven, AI-powered biopharmaceutical company that develops transformative medicines and vaccines. The company applies deep immunology expertise and cutting-edge artificial intelligence to its drug and vaccine development work across core therapeutic areas.
The company operates with a global team of over 100,000 employees and maintains a presence in more than 70 countries. Its clinical pipeline includes 80 compounds in development, with 28 currently in phase 3 trials.
Sanofi's technical work spans AI, R&D, drug development, and vaccine development. The company describes its culture as united by purpose, with a focus on collaboration, curiosity, and scientific progress.
